Method for identifying compounds for treatment of insulin resistance

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6630312
APP PUB NO 20010036625A1
SERIAL NO

09776432

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention features a method of identifying, evaluating or making a compound or agent, e.g., a candidate compound or agent, for treatment of a disorder characterized by insulin resistance. The method includes evaluating the ability of a compound or agent to bind IKK-.beta. or modulate IKK-.beta. activity, to thereby identify a compound or agent for the treatment of a disorder characterized by insulin resistance. The invention also features compounds for treating insulin resistance identified by such methods, and methods of treating a subject having a disorder characterized by insulin resistance by administering such agents.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JOSLIN DIABETES CENTER INCONE JOSLIN PLACE BOSTON MA 02215

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Shoelson, Steven Natick, MA 8 33

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation